- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT02644382
Improving Surgical Decision-making in Young Women With Breast Cancer
The overall goal of this study is to qualitatively assess the surgical decision-making process from both the patient and physician perspective
- Conduct short in-person interviews with young women prior to surgery
- Conduct focus groups with breast cancer survivors about their surgical decision and experience
- Interview surgical oncologists, plastic surgeons, medical and radiation oncologists about their experiences and how they communicate with breast cancer patients about local therapy decisions
- To survey women about surgical decision-making prior to and after their consult in conjunction with pilot testing of a web-based decision aid to support high quality surgical decision-making in newly diagnosed young women with breast cancer.
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Descrição detalhada
Breast cancer in young women: Breast cancer is the most common cancer diagnosed in women younger than age 40 in the United States, with approximately 14,000 new cases each year. Young women face unique psychosocial challenges, most notably fertility, sexuality, and image concerns and are at a life stage where education, career, and family are important priorities. Concern about these issues may contribute to the greater psychosocial distress seen in younger women at both diagnosis and in follow-up compared with older women. Importantly, these concerns may also influence treatment decisions including receipt of chemotherapy, adherence to endocrine therapy, and surgical decisions. Thus, attending to the unique issues of young women may enhance not only quality of care and quality of life (QOL) but also potentially disease outcomes.
Surgical management of breast cancer: Standard loco-regional management of breast cancer entails partial mastectomy (i.e., breast conserving surgery) followed by radiation or mastectomy with or without radiation. The decision depends on a number of factors including extent of disease, family history, BRCA mutation status, and personal preference. In recent years, an increasing number of women have elected to undergo contralateral prophylactic mastectomy (CPM) in conjunction with surgery of the affected breast (usually choosing bilateral mastectomy), despite a lack of clear evidence for survival benefit from this procedure in the vast majority of women. In weighing the benefits and risks of CPM, one must consider the absolute risk reduction of a new primary breast cancer (usually relatively modest in the average risk survivor), the long and short-term risks of this additional surgery including potential complications (bilateral mastectomy is associated with a greater risk of surgical complications) and the impact on QOL. At the same time, one must consider the competing risk of systemic recurrence of a woman's initial breast cancer. Young women, in particular, have the greatest risk of systemic recurrence and death from their original cancer, lowering the likelihood of benefit of CPM in preventing a new primary breast cancer. However, while CPM rates have increased among all breast cancer patients, increased rates of CPM are particularly pronounced among the youngest women with breast cancer, with several studies identifying young age at diagnosis as one of the strongest determinants of CPM.Physicians and researchers have been observing and discussing this trend for a number of years and yet little has been done to intervene.
The goal of the proposed research is to better understand and improve the surgical decision process in young women with breast cancer. Using qualitative research methods, we will comprehensively assess patient experiences - both patients who have had CPM and patients who did not - as well as physician perspectives regarding this decision. Based on these findings, the investigators will determine how to best improve the quality of the process, e.g., by correcting misperceptions, setting realistic expectations regarding the impact of surgery (including reconstruction) on QOL, improving communication with health care providers, and better management of anxiety surrounding diagnosis. This qualitative research is designed to build on prior quantitative analyses, by gaining an in depth perspective through focus groups and interviews, about certain issues identified as impacting the surgical decision process, including anxiety, fear of recurrence, and patient-physician communication.
Collectively, results from the qualitative assessment will inform a future phase of this research involving the design and subsequent development of a decision aid to help women make informed decisions about their breast cancer surgery.
The goal of this second phase of the research is to survey women about surgical decision-making prior to and after their consult in conjunction with pilot testing of a web-based decision aid to support high quality surgical decision-making in newly diagnosed young women with breast cancer.
Tipo de estudo
Inscrição (Real)
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Método de amostragem
População do estudo
Descrição
Inclusion Criteria:
Patients for key informant interviews-
- Newly diagnosed women with Stage 0-3 breast cancer
- Between the ages of 18 and 40 who are seen at DFCI and have not yet had their primary breast cancer surgery.
Patients for focus groups:
- diagnosis of Stage 0-3 breast cancer at age 40 and younger
- currently between the ages of 18-43
- English-speaking
- 1-3 years from diagnosis
- Had breast cancer surgery
- no evidence of recurrent or metastatic disease.
Providers:
Must care for women who have breast cancer. Can be surgeons, surgical oncologists, medical and/or radiation oncologists
Patients for Surgical Decision Making Pilot
- Women with newly-diagnosed, unilateral Stage 0-3 breast cancer
- Between the ages of 18 and 40
- Who are seen by a surgeon at DFCI/BWH or Faulkner Hospital
- English speaking
- Have not yet had their primary breast cancer surgery
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Modelos de observação: Outro
- Perspectivas de Tempo: Outro
Coortes e Intervenções
Grupo / Coorte |
Intervenção / Tratamento |
---|---|
Key Informant interviews
20 in-person or phone qualitative interviews with patients.
|
qualitative data collection
|
Focus Groups
four qualitative focus groups of 6-10 women each.
|
qualitative data collection
|
Physician Interviews
physician qualitative interviews over the telephone.
|
qualitative data collection
|
Usual care cohort (pilot)
50 women who will be surveyed before and after their surgical consult
|
survey pre and post-surgical consult
|
Decision aid cohort (pilot)
50 women who will be surveyed before and after their surgical consult and will also be sent a web-based decision aid
|
survey pre and post-surgical consult
web-based decision aid post-surgical consult
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
---|---|---|
Thematic summary from the data gathered from the use of a moderator guide (series of probing questions) that inquires about the experiences surrounding the surgical decision-making process from both the patient and physician perspective
Prazo: 1 year
|
The goal of the proposed research is to better understand and improve the surgical decision process in young women with breast cancer.
Using qualitative research methods, we will comprehensively assess patient experiences - both patients who have had CPM and patients who did not - as well as physician perspectives regarding this decision.
|
1 year
|
Breast cancer knowledge
Prazo: 2 weeks
|
Knowledge will be assessed using selected questions from the Breast Cancer Surgery Decision Quality Instrument (BCS-DQI), an instrument designed to evaluate the quality of breast cancer treatment decisions as well as additional true/false questions related to side effects of radiation.
|
2 weeks
|
Decisional conflict
Prazo: 2 weeks
|
Decisional conflict will be measured with the SURE scale.
The SURE scale is composed of four items from the Decisional Conflict Scale that measure patients' uncertainty about which treatment choice and factors contributing to uncertainty.
|
2 weeks
|
Anxiety
Prazo: 2 weeks
|
Anxiety will be assessed using the PROMIS Emotional Distress - Anxiety - Short Form.
|
2 weeks
|
Treatment goals and preferences
Prazo: 2 weeks
|
have been adapted from the BCS-DQI.
We will ask women to mark on a scale (not important - very important) the importance of several reasons in relation to their decision about surgery as well as concerns (not all concerned-very concerned) about local therapy.
|
2 weeks
|
Perception of decision process
Prazo: 2 weeks
|
Perception of the decision process will be assessed with an adapted version of the Control Preferences Scale.
|
2 weeks
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
---|---|---|
Usability of decision aid (DA)
Prazo: 2 weeks-1 month
|
Assessment of what patients did and did not like about the DA, ways they think the DA can be improved, and how they felt the DA affected communication with their physician.
|
2 weeks-1 month
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Shoshana Rosenberg, ScD, Dana-Farber Cancer Institute
Publicações e links úteis
Publicações Gerais
- Rosenberg SM, Greaney ML, Patenaude AF, Sepucha KR, Meyer ME, Partridge AH. "I don't want to take chances.": A qualitative exploration of surgical decision making in young breast cancer survivors. Psychooncology. 2018 Jun;27(6):1524-1529. doi: 10.1002/pon.4683. Epub 2018 Apr 6.
- Rosenberg SM, Greaney ML, Patenaude AF, Partridge AH. Factors Affecting Surgical Decisions in Newly Diagnosed Young Women with Early-Stage Breast Cancer. J Adolesc Young Adult Oncol. 2019 Aug;8(4):463-468. doi: 10.1089/jayao.2019.0002. Epub 2019 Apr 3.
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Real)
Conclusão do estudo (Real)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Estimativa)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- 15-288
- 1K01HS023680-01A1 (Concessão/Contrato da AHRQ dos EUA)
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .
Ensaios clínicos em Câncer de mama
-
Turku University HospitalLounais-Suomen SyöpäyhdistysAinda não está recrutandoSobrevivente de cancerFinlândia
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)RetiradoSobrevivente de cancerEstados Unidos
-
University of Alabama at BirminghamNational Cancer Institute (NCI); Auburn UniversityConcluído
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI)ConcluídoSobrevivente de cancerEstados Unidos
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)ConcluídoSobrevivente de cancerEstados Unidos, Guam
-
Wake Forest University Health SciencesNational Cancer Institute (NCI); National Institute of Mental Health (NIMH)ConcluídoSobrevivente de cancerEstados Unidos
-
Masonic Cancer Center, University of MinnesotaConcluídoSobrevivente de cancerEstados Unidos
-
Abramson Cancer Center of the University of PennsylvaniaConcluídoPlano de cuidados de sobrevivência LIVESTRONG: coleta contínua de dados e pesquisa de acompanhamentoPaciente com cancerEstados Unidos
-
University of New MexicoNew Mexico State University; University of New Mexico Cancer CenterConcluído
-
Ohio State University Comprehensive Cancer CenterConcluídoSobrevivente de cancerEstados Unidos
Ensaios clínicos em qualitative data collection
-
Northeastern UniversityRhode Island HospitalConcluído
-
Cliniques universitaires Saint-Luc- Université...Université de LiègeRecrutamentoNovos marcadores da função reguladora da condutância transmembrana da fibrose cística (CFTR) no suorFibrose cística | BiomarcadoresBélgica
-
State University of New York at BuffaloEunice Kennedy Shriver National Institute of Child Health and Human Development... e outros colaboradoresConcluído
-
Newcastle UniversityConcluídoEstado de saúdeReino Unido
-
GlaxoSmithKlineQuintiles IMSConcluído
-
IRCCS National Neurological Institute "C. Mondino...IRCCS Associazione Oasi Maria SS. ONLUS, Troina, Italy; IRCCS Istituto Auxologico... e outros colaboradoresConcluídoDoença de Alzheimer | Comprometimento cognitivo leveItália
-
Xim LimitedConcluídoDoenças cardiovasculares | Diabetes | Cuidados intensivos | Atenção Primária | Distúrbio Respiratório | Trauma e Atendimento de EmergênciaReino Unido
-
Steno Diabetes Center CopenhagenUniversity of Southern Denmark; Steno Diabetes Center SjaellandAtivo, não recrutandoData Health VET - Promoção da Saúde Orientada por Dados em Escolas de Ensino e Formação ProfissionalBem-estar | Consumo de álcool | Uso de drogas | Hábitos alimentares | Comportamentos de fumar | Inatividade físicaDinamarca
-
Xim LimitedPortsmouth Hospitals NHS Trust; Mind Over Matter Medtech LtdConcluído
-
Meir Medical CenterAmbulatory Pediatric AssociationConcluído